Trial intelligence / Profile preview

aMAT vs PRP in Knee Osteoarthritis

NCT03117608Phase 4Unknown

Sponsor
Lipogems
Start
Feb 2017
Primary completion
Aug 2022
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 4 trial of autologous micro-fragmented adipose tissue in osteoarthritis (OA), sponsored by Lipogems. Status: unknown.

02

Drugs

autologous micro-fragmented adipose tissue
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03117608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03117608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call